JP2005519978A5 - - Google Patents

Download PDF

Info

Publication number
JP2005519978A5
JP2005519978A5 JP2003579795A JP2003579795A JP2005519978A5 JP 2005519978 A5 JP2005519978 A5 JP 2005519978A5 JP 2003579795 A JP2003579795 A JP 2003579795A JP 2003579795 A JP2003579795 A JP 2003579795A JP 2005519978 A5 JP2005519978 A5 JP 2005519978A5
Authority
JP
Japan
Prior art keywords
keto
eye drop
prostaglandin compound
group
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003579795A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005519978A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2003/001181 external-priority patent/WO2003082257A2/en
Publication of JP2005519978A publication Critical patent/JP2005519978A/ja
Publication of JP2005519978A5 publication Critical patent/JP2005519978A5/ja
Withdrawn legal-status Critical Current

Links

JP2003579795A 2002-03-28 2003-03-26 高眼圧症および緑内障の処置方法 Withdrawn JP2005519978A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36772202P 2002-03-28 2002-03-28
PCT/IB2003/001181 WO2003082257A2 (en) 2002-03-28 2003-03-26 Method for treating ocular hypertension and glaucoma

Publications (2)

Publication Number Publication Date
JP2005519978A JP2005519978A (ja) 2005-07-07
JP2005519978A5 true JP2005519978A5 (https=) 2005-08-18

Family

ID=28675389

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003579795A Withdrawn JP2005519978A (ja) 2002-03-28 2003-03-26 高眼圧症および緑内障の処置方法

Country Status (6)

Country Link
US (1) US20030220396A1 (https=)
JP (1) JP2005519978A (https=)
AR (1) AR039167A1 (https=)
AU (1) AU2003215820A1 (https=)
TW (1) TW200400039A (https=)
WO (1) WO2003082257A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040225014A1 (en) * 2003-02-14 2004-11-11 Sucampo Ag Method for treating ocular hypertension and glaucoma
TW201309343A (zh) * 2011-02-10 2013-03-01 參天製藥股份有限公司 經改善親水性藥物之藥物移行性之水性組成物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166178B1 (en) * 1987-09-18 1998-07-21 R Tech Ueno Ltd Ocular hypotensive agents
US5151444B1 (en) * 1987-09-18 1999-07-06 R Tech Ueno Ltd Ocular hypotensive agents
US5212200A (en) * 1987-09-18 1993-05-18 R-Tech Ueno, Ltd. Ocular hypotensive agents
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
EP0366279B1 (en) * 1988-10-01 1994-09-21 R-Tech Ueno Ltd. Ocular hypotensive agents
US5175189A (en) * 1990-05-22 1992-12-29 K.K. Ueno Seiyaku Oyo Kenkyujo Treatment of ocular hypertension with a synergistic combination for ophthalmic use
DK0458590T3 (da) * 1990-05-22 1996-02-05 R Tech Ueno Ltd Behandling af okulær hypertension med en synergistisk konbination
AU687906B2 (en) * 1993-12-15 1998-03-05 Alcon Laboratories, Inc. Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
CA2274708A1 (en) * 1997-10-13 1999-04-22 R-Tech Ueno, Ltd. Remedial composition for intraocular hypertension or glaucoma
DE69909768T2 (de) * 1998-04-07 2004-06-17 Alcon Manufacturing Ltd., Fort Worth Xanthangummi enthaltende gelbildende ophthalmische zusammensetzungen
US6458836B1 (en) * 2000-03-16 2002-10-01 Sucampo, A.G. Treatment of ocular hypertension and glaucoma
AU2001241143B2 (en) * 2000-03-16 2005-08-25 Sucampo Ag Composition for use in treatment of ocular hypertension and glaucoma
US20020035148A1 (en) * 2000-07-20 2002-03-21 Ryuji Ueno Treatment of ocular hypertension
US6414021B1 (en) * 2000-08-25 2002-07-02 Sucampo Ag Control of intraocular pressure during surgery
KR20040008174A (ko) * 2001-05-14 2004-01-28 수캄포 아게 고안압증 및 녹내장 치료방법
MXPA04000980A (es) * 2001-07-31 2004-04-20 Sucampo Ag Tratamiento de hipertension ocular y glaucoma.
WO2003018025A1 (en) * 2001-08-23 2003-03-06 Sucampo Ag Method and composition for treatment of ocular hypertension and glaucoma

Similar Documents

Publication Publication Date Title
JP2008531468A5 (https=)
CA2600331A1 (en) Use of 11-deoxy-prostaglandin for treating peripheral vascular diseases
CN100335049C (zh) 泻药组合物
JP2592204B2 (ja) 眼圧降下剤
JP2004527567A5 (https=)
JP2005504836A5 (https=)
CA2377661A1 (en) Use of fatty acid derivative for the treatment of external secretion disorders
RU2002103597A (ru) Композиция для лечения нарушений внешней секреции
JPH0667900B2 (ja) プロスタグランジンf類
JP2003504397A5 (https=)
JP2006513232A5 (https=)
CA2444103A1 (en) Composition for treating drug-induced constipation with 15-keto-prostaglandins
JP5907077B2 (ja) 二環式化合物およびその医薬用途
JP4319256B2 (ja) エンドセリン拮抗剤
JP2006506381A5 (https=)
JP2007518685A5 (https=)
JP2004529960A5 (https=)
JP2004519412A5 (https=)
JP2004529177A5 (https=)
JP2009525970A5 (https=)
JP2008528440A5 (https=)
CA2445651A1 (en) Cathartic composition comprising halogenated prostaglandin derivatives
JP2005519978A5 (https=)
JP2004538306A5 (https=)
RU2440338C2 (ru) Способ и композиция для лечения заболеваний центральной нервной системы